Skip to main navigation Skip to search Skip to main content

Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: Results of a worldwide expanded access program study

  • B. L. Samuels
  • , S. Chawla
  • , S. Patel
  • , M. von Mehren
  • , J. Hamm
  • , P. E. Kaiser
  • , S. Schuetze
  • , J. Li
  • , A. Aymes
  • , G. D. Demetri
  • Kootenai Cancer Center
  • Sarcoma Oncology Center
  • University of Texas MD Anderson Cancer Center
  • Norton Cancer Institute
  • Oncology Specialists
  • University of Michigan, Ann Arbor
  • Department of Oncology Biostatistics
  • Johnson & Johnson
  • Dana-Farber Cancer Institute

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: Results of a worldwide expanded access program study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science